Jto Clinical And Research Reports

SCIE

国际简称：Jto Clin Res Rep 参考译名：Jto临床和研究报告

主要研究方向：Medicine-Oncology 非预警期刊审稿周期：19 Weeks

《Jto临床和研究报告》(Jto Clinical And Research Reports)是一本由Elsevier出版的以Medicine-Oncology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q2 JCR分区
120 年发文量
3.6 IF影响因子
未开放 是否OA
English 出版语言

Jto Clinical And Research Reports is an international open access journal that covers a wide range of fields in medicine and clinical research. The magazine aims to provide a platform for researchers, doctors, scholars, and professionals worldwide to share and disseminate the latest research findings, innovative clinical practices, and technological developments. The main goal of the magazine is to promote knowledge exchange and collaboration in the medical field, encourage original research, case reports, review articles, brief communications, and other forms of academic contributions that not only contribute to advancing scientific research, but also provide practical information for clinical doctors to improve patient diagnosis and treatment. This magazine is aimed at medical researchers, clinical doctors, medical students, pharmacologists, biostatisticians, and other experts and scholars in related fields worldwide. By providing high-quality research results, it meets the needs of these professionals for the latest medical information.

[ 查看全部 ]

投稿咨询加急咨询

Jto Clinical And Research Reports期刊信息

ISSN：2666-3643
出版语言：English
是否OA：未开放
出版地区：United States
是否预警：否
出版商：Elsevier
Gold OA文章占比：100.00%
研究类文章占比：93.33%

Jto Clinical And Research Reports CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

6.3

1.708

1.134

学科类别	分区	排名	百分位
大类：Medicine 小类：Pulmonary and Respiratory Medicine	Q1	33 / 165	80%
大类：Medicine 小类：Oncology	Q1	98 / 428	77%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Jto Clinical And Research Reports中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统	3区 3区

Jto Clinical And Research Reports JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	ESCI	Q2	132 / 333	60.5
学科：RESPIRATORY SYSTEM	ESCI	Q2	31 / 107	71.5
学科：ONCOLOGY	ESCI	Q2	96 / 333	71.32
学科：RESPIRATORY SYSTEM	ESCI	Q2	29 / 107	73.36

Jto Clinical And Research Reports历年数据统计

影响因子

中科院分区

Jto Clinical And Research Reports中国学者发文选摘

1、Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Stud
Author: Ahn, Myung-Ju; Tan, Daniel Sw.; Windsor, Morgan; Ong, Boon-Hean; Ho, James Chung-Man; Kim, Hong Kwan; Lee, Victor Ho-Fun; Hsu, Feng-Ming; Shih, Jin Yuan; Pham, Duc Nhat Minh; Pham, Cam Phuong; Chua, Sharon; Yeo, See-Hwee; De Dios, Ivy

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2026; Vol. 7, Issue 3, pp. -. DOI: 10.1016/j.jtocrr.2025.100945
2、The Landscape of CEACAM5 Expression by Immunohistochemistry in NSCL
Author: Hsu, Ying-Han R.; Almutrafi, Amna; Hueniken, Katrina; Azaizeh, Alhareth; Hou, Likun; Li, Quan; Bates, Mackenzie; Pham, Nhu-An; Tsao, Ming-Sound

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2026; Vol. 7, Issue 2, pp. -. DOI: 10.1016/j.jtocrr.2025.100943
3、Unmasking the Hidden Cardiopulmonary Cost of Lobectomy: A Paradigm Shift Demanded by Exercise Hemodynamic
Author: Wu, Qiang; Lv, Zhenyang; Fan, Zhe; Wang, Ze; Su, Hao; Lei, Ting

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2026; Vol. 7, Issue 1, pp. -. DOI: 10.1016/j.jtocrr.2025.100936
4、Patient-Reported Outcomes From LIBRETTO-431 : First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCL
Author: Zhou, Caicun; Novello, Silvia; Garrido, Pilar; Dooms, Christophe; Alatorre-Alexander, Jorge; Reinmuth, Niels; Worthy, Gill; Cocks, Kim; Williams, Justin; Han, Hongmei; Uh, Minji K.; Payakachat, Nalin; Gilligan, Adrienne M.; Goto, Koichi

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2025; Vol. 6, Issue 7, pp. -. DOI: 10.1016/j.jtocrr.2025.100814
5、The Landscape of MET Exon 14 Skipping Mutations in Patients With Lung Cancer Identified by Next-Generation Sequencin
Author: Liao, Jia; Wu, Song; Min, Yi; Li, Yiran; Nie, Yuanhang; Chen, Quwen; Mao, Zhiliang; Zong, Qinglan; Gao, Ning; Zhang, Ding; Liang, Weiquan

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2025; Vol. 6, Issue 7, pp. -. DOI: 10.1016/j.jtocrr.2025.100826
6、A Phase II Clinical Trial of Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced High-Grade Thymic Tumor
Author: Xu, Ning; Wang, Changlu; Zhang, Qin; Hao, Xiuxiu; Mao, Teng; Shi, Jianxin; Gu, Zhitao; Gao, Lanting; Shen, Yan; Zhu, Lei; Zhang, Xuefei; Liu, Yuan; Fang, Wentao

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2025; Vol. 6, Issue 6, pp. -. DOI: 10.1016/j.jtocrr.2025.100821
7、Impact of Prophylactic Use of PEG-rhG-CSF on First-Line Immunochemotherapy in Advanced NSCLC: A Cohort Stud
Author: Sun, Li; Tian, Yuan; Zhang, Shuling; Huang, Letian; Ma, Jietao; Han, Chengbo

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2025; Vol. 6, Issue 2, pp. -. DOI: 10.1016/j.jtocrr.2024.100780
8、Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Repor
Author: Dong, Yichen; Xu, Long; Wen, Jialiang; Si, Haojie; Yu, Juemin; Chen, Tao; Xie, Huikang; Li, Xinjian; Yang, Minglei; Fan, Junqiang; Wu, Junqi; She, Yunlang; Zhao, Deping; Chen, Chang

Journal: JTO CLINICAL AND RESEARCH REPORTS. 2025; Vol. 6, Issue 1, pp. -. DOI: 10.1016/j.jtocrr.2024.100763